Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Mylan Laboratories Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

MYLAN LABORATORIES LIMITED

www.mylan.in

Active

Updated: 04 Nov 2024

The company manufactures and supplies active pharmaceutical ingredients, finished dosage formulations and injectables; and engages in research and development activities.

Mylan Laboratories Limited, is an unlisted public company incorporated on 29 November, 1984. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 125.00 cr and the total paid-up capital is INR 48.70 cr.

Industry

Manufacturing of Pharmaceuticals

Products

HIV Care Products, Critical Care Products, Onco Care Products and Other Products., Hepato Care Products

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

-9.35%

₹ 9,711.7

EBITDA

-6.85%

₹ 1,430.5

Net Profit

-45.93%

₹ 259.7

Networth

-41.08%

₹ 5,602.8

Borrowings

-8.55%

₹ 3,729.3

Assets

-28.74%

₹ 12,670.8

Gross Margin

-8.04

49.6 %

Operating Margin

0.4

14.7 %

Net Profit Margin

-1.68

2.7 %

Return on Equity

-0.41

4.6 %

ROCE

5.78

9.4 %

Debt to Equity

0.24

0.7

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (29)

State	Type	Address

Locations on Map

Tofler Score

Good

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

LOW ROCE
LOW CASH BALANCE
REVENUE BELOW AVERAGE

Low Risk

HIGH INVENTORY
NET MARGIN DETERIORATING

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	12,238.6	12,958.3	11,543.2	10,713.5	9,711.7
Operating profit	2,266.2	2,499.5	1,621.4	1,535.8	1,430.5
Net profit	181.6	1,112.3	642.8	480.3	259.7
Gross margin	50.1	51.9	51.6	57.7	49.6
Operating margin	18.5	19.3	14.1	14.3	14.7
Net margin	1.4	8.3	5.4	4.4	2.7
Networth	7,059.7	8,588.2	9,137.2	9,509.3	5,602.8
Borrowings	8,240.8	5,940.2	5,126.3	4,077.9	3,729.3
Assets	19,404.8	19,045.0	17,689.3	17,782.1	12,670.8
Debt to equity	1.2	0.7	0.6	0.4	0.7
Current ratio	3.1	2.8	2.5	2.2	2.7
ROE	2.6	12.9	7.0	5.0	4.6
Days payable	145.0	152.0	146.0	232.0	161.0
WC days	224.0	199.0	191.0	189.0	185.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	48.7	48.7	48.7	48.7	48.7
Reserves	7,011.0	8,539.5	9,088.5	9,460.6	5,554.1
Borrowings +	8,240.8	5,940.2	5,126.3	4,077.9	3,729.3
Long term borrowings	8,240.8	5,940.2	4,178.9	3,153.0	3,729.3
Short term borrowings	-	-	947.4	924.9	-
Trade payables +	2,431.9	2,586.3	2,230.3	2,884.5	2,156.3
Days payable	145.0	152.0	146.0	232.0	161.0
Other liabilities +	4,104.3	4,516.6	3,425.9	4,194.9	3,338.6
Other non-current liabilities	548.4	504.7	480.5	455.8	464.2
Other current liabilities	1,123.9	1,425.6	715.0	854.5	718.1
Total liabilities	19,404.8	19,045.0	17,689.3	17,782.1	12,670.8
Fixed Assets +	7,950.6	7,441.2	6,952.8	6,712.1	4,174.5
Tangible assets	4,402.7	4,344.9	4,251.2	4,722.9	3,087.1
CWIP	434.6	369.1	609.1	525.9	712.4
Intangible assets	3,113.3	2,727.2	2,092.4	1,463.2	375.0
LT loans and advances	-	-	-	-	-
Other non-current assets	393.8	539.5	814.6	853.2	698.9
Current assets +	11,060.4	11,064.3	9,922.0	10,216.7	7,797.3
Inventories	4,439.1	4,538.0	4,910.1	5,421.9	3,309.8
Trade receivables	5,083.8	5,013.0	3,914.8	3,945.2	3,631.0
Cash and cash equivalents	177.8	65.3	37.3	5.2	126.2
ST loans and advances	324.1	242.1	242.1	-	-
Other current assets	1,035.6	1,206.0	817.7	844.4	730.3
Total assets	19,404.8	19,045.0	17,689.3	17,782.1	12,670.8

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.25	0.26	0.28	0.27	0.38
Reserves	36.13	44.84	51.38	53.2	43.83
Borrowings +	42.47	31.19	28.98	22.93	29.43
Long term borrowings	42.47	31.19	23.62	17.73	29.43
Short term borrowings	0.0	0.0	5.36	5.2	0.0
Trade payables	12.53	13.58	12.61	16.22	17.02
Other liabilities +	21.15	23.72	19.37	23.59	26.35
Other non-current liabilities	2.83	2.65	2.72	2.56	3.66
Other current liabilities	5.79	7.49	4.04	4.81	5.67
Total liabilities
Fixed Assets +	40.97	39.07	39.3	37.75	32.95
Tangible assets	22.69	22.81	24.03	26.56	24.36
CWIP	2.24	1.94	3.44	2.96	5.62
Intangible assets	16.04	14.32	11.83	8.23	2.96
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	2.03	2.83	4.6	4.8	5.52
Current assets +	57.0	58.1	56.09	57.46	61.54
Inventories	22.88	23.83	27.76	30.49	26.12
Trade receivables	26.2	26.32	22.13	22.19	28.66
Cash and cash equivalents	0.92	0.34	0.21	0.03	1.0
ST loans and advances	1.67	1.27	1.37	0.0	0.0
Other current assets	5.34	6.33	4.62	4.75	5.76
Total assets

	Mar 2016	Mar 2017
Equity Capital	48.7	48.7
Reserves	8,342.2	8,064.0
Borrowings +	9,156.8	8,939.7
Long term borrowings	8,716.2	8,738.7
Short term borrowings	440.6	201.0
Trade payables +	1,815.3	1,578.0
Days payable	139.0	121.0
Other liabilities +	3,436.4	3,101.6
Other non-current liabilities	644.7	453.0
Other current liabilities	976.4	1,070.6
Total liabilities	20,984.1	20,154.0
Fixed Assets +	11,613.7	10,899.8
Tangible assets	3,481.2	3,609.6
CWIP	804.7	762.1
Intangible assets	7,327.8	6,528.2
LT loans and advances	-	-
Other non-current assets	655.6	562.2
Current assets +	8,714.8	8,692.0
Inventories	3,759.3	3,477.3
Trade receivables	3,126.3	3,598.1
Cash and cash equivalents	54.1	129.4
ST loans and advances	261.3	217.0
Other current assets	1,513.8	1,270.2
Total assets	20,984.1	20,154.0

Percentage of assets	Mar 2016	Mar 2017
Equity Capital	0.23	0.24
Reserves	39.75	40.01
Borrowings +	43.64	44.36
Long term borrowings	41.54	43.36
Short term borrowings	2.1	1.0
Trade payables	8.65	7.83
Other liabilities +	16.38	15.39
Other non-current liabilities	3.07	2.25
Other current liabilities	4.65	5.31
Total liabilities
Fixed Assets +	55.35	54.08
Tangible assets	16.59	17.91
CWIP	3.83	3.78
Intangible assets	34.92	32.39
LT loans and advances	0.0	0.0
Other non-current assets	3.12	2.79
Current assets +	41.53	43.13
Inventories	17.92	17.25
Trade receivables	14.9	17.85
Cash and cash equivalents	0.26	0.64
ST loans and advances	1.25	1.08
Other current assets	7.21	6.3
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	12,238.6	12,958.3	11,543.2	10,713.5	9,711.7
Sales growth %	11.57	5.88	-10.92	-7.19	-9.35
Expenses +	12,066.9	12,465.9	11,526.6	10,509.5	9,270.3
Cost of goods	6,107.3	6,230.2	5,591.6	4,535.8	4,892.4
Employee cost	1,195.5	1,433.3	1,471.4	1,577.9	1,414.5
Other costs	2,669.6	2,795.3	2,858.8	3,064.0	1,974.4
Operating profit +	2,266.2	2,499.5	1,621.4	1,535.8	1,430.5
Operating margin %	18.5	19.3	14.1	14.3	14.7
Other income	246.8	479.9	457.7	241.5	50.0
Interest	849.9	744.3	550.8	239.0	413.1
Depreciation	1,244.6	1,262.9	1,054.0	1,092.8	576.0
Exceptional items	-	-	-	-	-
Profit before tax	418.5	972.3	474.4	445.5	491.4
Tax	236.9	-140.0	-168.4	-34.8	85.2
Profit - disc. ops	-	-	-	-	-146.5
Net profit	181.6	1,112.3	642.8	480.3	259.7
Net margin %	1.4	8.3	5.4	4.4	2.7

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	98.02	96.43	96.19	97.8	99.49
Expenses +	96.65	92.76	96.05	95.93	94.97
Cost of goods	48.92	46.36	46.59	41.4	50.12
Employee cost	9.57	10.67	12.26	14.4	14.49
Other costs	21.38	20.8	23.82	27.97	20.23
Operating profit	18.15	18.6	13.51	14.02	14.65
Other income	1.98	3.57	3.81	2.2	0.51
Interest	6.81	5.54	4.59	2.18	4.23
Depreciation	9.97	9.4	8.78	9.97	5.9
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	3.35	7.24	3.95	4.07	5.03
Tax	1.9	-1.04	-1.4	-0.32	0.87
Profit - disc. ops	0.0	0.0	0.0	0.0	-1.5
Net profit	1.45	8.28	5.36	4.38	2.66

	Mar 2016	Mar 2017
Sales +	9,506.3	9,622.8
Sales growth %	None	1.23
Expenses +	10,079.2	10,662.3
Cost of goods	4,780.5	4,746.7
Employee cost	806.6	1,008.0
Other costs	2,664.9	2,369.5
Operating profit +	1,254.3	1,498.7
Operating margin %	13.2	15.6
Other income	345.3	402.1
Interest	636.4	856.9
Depreciation	1,190.8	1,681.2
Exceptional items	-	-
Profit before tax	-227.6	-637.3
Tax	-172.1	-167.8
Profit - disc. ops	-	-
Net profit	-55.4	-469.6
Net margin %	-0.6	-4.7

Precentage of total income	Mar 2016	Mar 2017
Sales	96.49	95.99
Expenses +	102.31	106.36
Cost of goods	48.52	47.35
Employee cost	8.19	10.05
Other costs	27.05	23.64
Operating profit	12.73	14.95
Other income	3.51	4.01
Interest	6.46	8.55
Depreciation	12.09	16.77
Exceptional items	0.0	0.0
Profit before tax	-2.31	-6.36
Tax	-1.75	-1.67
Profit - disc. ops	0.0	0.0
Net profit	-0.56	-4.68

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	1.2	0.7	0.6	0.4	0.7
Net Debt/Equity	1.1	0.7	0.6	0.4	0.6
Total Debt/Assets	0.4	0.3	0.3	0.2	0.3
Total Assets/Equity	2.8	2.2	1.9	1.9	2.3
Liquidity +
Current Ratio	3.1	2.8	2.5	2.2	2.7
Quick Ratio	1.9	1.6	1.3	1.0	1.6
Interest Coverage	2.7	3.4	2.9	6.4	3.5
Performance
Gross Margin	50.1	51.9	51.6	57.7	49.6
Operating Margin	18.5	19.3	14.1	14.3	14.7
Net Margin	1.4	8.3	5.4	4.4	2.7
Return +
Return on Equity	2.6	12.9	7.0	5.0	4.6
Pre-tax ROCE	6.6	8.5	4.4	3.6	9.4
Return on Assets	0.9	5.8	3.6	2.7	2.0
Pre-tax ROIC	6.8	8.6	4.0	3.3	9.3
Efficiency +
Days Payable	145.0	152.0	146.0	232.0	161.0
Days Inventory	265.0	266.0	321.0	436.0	247.0
Days Receivable	152.0	141.0	124.0	134.0	136.0
Fixed Asset Turnover	1.5	1.7	1.7	1.6	2.3
Total Asset Turnover	0.6	0.7	0.7	0.6	0.8
Working Capital
Cash Conversion Cycle	272.0	255.0	299.0	338.0	222.0
Working Capital Days	224.0	199.0	191.0	189.0	185.0

	Mar 2016	Mar 2017
Solvency +
Total Debt/Equity	1.1	1.1
Net Debt/Equity	1.1	1.1
Total Debt/Assets	0.4	0.4
Total Assets/Equity	2.5	2.5
Liquidity +
Current Ratio	2.7	3.0
Quick Ratio	1.5	1.8
Interest Coverage	2.0	1.8
Performance
Gross Margin	49.7	50.7
Operating Margin	13.2	15.6
Net Margin	-0.6	-4.7
Return +
Return on Equity	-0.7	-5.8
Pre-tax ROCE	0.4	-1.1
Return on Assets	-0.3	-2.3
Pre-tax ROIC	0.4	-1.1
Efficiency +
Days Payable	139.0	121.0
Days Inventory	287.0	267.0
Days Receivable	120.0	136.0
Fixed Asset Turnover	0.8	0.9
Total Asset Turnover	0.5	0.5
Working Capital
Cash Conversion Cycle	268.0	282.0
Working Capital Days	211.0	222.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

As per information available, the company has no registered charges.

People

Designation	Name	DIN/PAN	Tenure
Director	Rajiv Malik	00120557	20 years
Whole-time Director	Sarada Kalyani Bhagawati Shareholder	02680074	10 years
Kmp	Sarada Kalyani Bhagawati	<HIDDEN>	10 years
CS	Nagaraj Goud Bodige Shareholder	<HIDDEN>	14 years
Director	Akshay Nanda	10517236	1 years
Director	Arvind Shankar Kanda	10560284	1 years
Director	Ramya Suresh	10603923	1 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
BIOCON BIOLOGICS LIMITED	Active	1,758.3 Cr	1	Karnataka
ASTRIX LABORATORIES LIMITED	Amalgamated	4.5 Cr	1	Telangana
MADAUS PHARMACEUTICALS PRIVATE LIMITED	Amalgamated	33.0 Cr	1	Telangana
JAI PHARMA LIMITED	Amalgamated	1.7 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Famy Care Europe Limited	United Kingdom	-	-

Registered Details

CIN

U24231TG1984PLC005146

PAN

AADCM3491M

Incorporation

1984, 40.4 years

Company Email

nagaraj.bodige@viatris.com

Paid up Capital

₹ 48.7 Cr

Authorised Capital

₹ 125.0 Cr

AGM

Sep 2024

Type

Public

Non-government Company

FAQ - MYLAN LABORATORIES LIMITED

What is the incorporation date of MYLAN LABORATORIES LIMITED?

The incorporation date of MYLAN LABORATORIES LIMITED is 29 November, 1984

What is the authorized share capital of MYLAN LABORATORIES LIMITED?

The authorized share capital of MYLAN LABORATORIES LIMITED is INR ₹ 125.0 Cr.

What is the paid-up capital of MYLAN LABORATORIES LIMITED?

The paid-up capital of MYLAN LABORATORIES LIMITED is INR ₹ 48.7 Cr.

What is the registered address of MYLAN LABORATORIES LIMITED?

The registered address of MYLAN LABORATORIES LIMITED is Plot No.564/A/22 Road No.92 Jubilee Hills Hyderabad Hyderabad Telangana - 500096

What is the CIN number of MYLAN LABORATORIES LIMITED?

The CIN number of MYLAN LABORATORIES LIMITED is U24231TG1984PLC005146.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

MYLAN LABORATORIES LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

People

Company Network